Table 2.
Characteristics of study subjects
| NPH/regular | Detemir/aspart | |
|---|---|---|
| No. of patients | 63 | 67 |
| Age (yr) | 58 ± 10 | 59 ± 10 |
| Gender (males/females) (n) | 30/33 | 30/37 |
| Race (B/W/H) | 39/12/12 | 44/14/9 |
| Body weight (kg) | 99 ± 29 | 91 ± 25 |
| Body mass index (kg/m2) | 34 ± 13 | 33 ± 8 |
| Diabetes treatment prior to admission, n (%) | ||
| Insulin | 24 (38) | 33 (49) |
| Insulin plus oral agents | 10 (16) | 6 (9) |
| Oral agent monotherapy | 14 (22) | 13 (19) |
| Multiple oral agents | 8 (13) | 10 (15) |
| No pharmacological agents | 7 (11) | 5 (8) |
| BG on admission (mg/dl) | 231 ± 145 | 230 ± 102 |
| BG prior treatment (mg/dl) | 223 ± 58 | 228 ± 54 |
| Hemoglobin A1C (%) | 8.1 ± 2 | 8.5 ± 2 |
| Creatinine (mg/dl) | 1.1 ± 0.3 | 1.2 ± 0.3 |
Data are means ± sd. To convert the values for BG from mg/dl to millimoles/liter, multiply by 0.05551. B, Black; W, White; H, Hispanic.